KREBS BIOCHEMICALS & IND (KREBSBIO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.

KREBSBIOUpdated 31 Aug 2026, 20:44

Krebs Biochemicals & Ind

Market Cap

₹124Cr.

Current Price

₹56.3

High / Low

₹82.5/38.3

ROE%
ROCE-15.4%
Book Value₹-75.5
Face Value₹10.0
Dividend Yield0.00%

About

Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1018032222541400
Inventory Days14,7042,162337142345234230170543396
Days Payable32,2504,3605103395212923402171,0511,192
Cash Conversion Cycle-17,536-2,018-170-175-174-57-106-44-494-7950
Working Capital Days-6,532-2,132-275-315-267-187-261-232-322-787-1,593
ROCE %-8%-26%-26%-26%-36%-57%-40%-57%-29%-19%-30%-15%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 20:44


Designed & Shipped by Harshit Bansal